Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2007 | 12-2006 | 12-2005 | 12-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,690 | -15,100 | -26,280 | -20,540 | -9,350 |
| Depreciation Amortization | 1,700 | 1,360 | 1,070 | 1,110 | -1,360 |
| Other Working Capital | -11,520 | 1,890 | -4,870 | 1,150 | -480 |
| Other Operating Activity | 4,390 | -11,000 | 620 | 610 | 650 |
| Operating Cash Flow | $-31,120 | $-22,850 | $-29,460 | $-17,670 | $-10,540 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -840 | -170 | -400 | -500 | -80 |
| Other Investing Activity | -1,200 | 6,280 | 22,720 | -6,330 | -24,580 |
| Investing Cash Flow | $-2,040 | $6,110 | $22,320 | $-6,830 | $-24,660 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 9,570 | 18,900 | 24,430 | 23,920 | 34,110 |
| Financing Cash Flow | $9,570 | $18,900 | $24,430 | $23,920 | $34,110 |
| Beginning Cash Position | 32,500 | 30,330 | 13,040 | 13,630 | 14,720 |
| End Cash Position | 8,910 | 32,500 | 30,330 | 13,040 | 13,630 |
| Net Cash Flow | $-23,590 | $2,170 | $17,290 | $-580 | $-1,090 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,120 | -22,850 | -29,460 | -17,670 | -10,540 |
| Free Cash Flow | -31,120 | -22,850 | -29,460 | -17,670 | -10,540 |